Literature DB >> 11311493

Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix.

T H Cheung1, M M Yu, K W Lo, S F Yim, T K Chung, Y F Wong.   

Abstract

Amplification and overexpression of cyclin D1 and CDK4 genes in cervical carcinoma were studied by semi-quantitative differential polymerase chain reaction assay and an immunostaining technique, respectively. Amplifications of cyclin D1 and CDK4 genes were found in 24% (27/113) and 26% (29/112) of tumors, respectively. Overexpression of cyclin D1 and CDK4 was demonstrated in 32% (21/66) and 73% (45/62) of tumors, respectively. No tumor showed CDK4 gene mutation on single strand conformational polymorphism. Sixteen percent (8/49) of the tumor specimens showed neither amplification nor overexpression. Disease stage, tumor grade and overexpression of cyclin D1 were found to be independent poor prognostic factors in cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311493     DOI: 10.1016/s0304-3835(01)00457-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

1.  Over-expression of cyclin D1 regulates Cdk4 protein synthesis.

Authors:  M A Parker; N G Deane; E A Thompson; R H Whitehead; S K Mithani; M K Washington; P K Datta; D A Dixon; R D Beauchamp
Journal:  Cell Prolif       Date:  2003-12       Impact factor: 6.831

2.  BIRC2 amplification in squamous cell carcinomas of the uterine cervix.

Authors:  M Choschzick; A M Tabibzada; F Gieseking; L Woelber; F Jaenicke; G Sauter; R Simon
Journal:  Virchows Arch       Date:  2012-06-26       Impact factor: 4.064

3.  Involvement of nuclear factor of activated T cells 3 (NFAT3) in cyclin D1 induction by B[a]PDE or B[a]PDE and ionizing radiation in mouse epidermal Cl 41 cells.

Authors:  Jin Ding; Ronghe Zhang; Jingxia Li; Caifang Xue; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2006-04-28       Impact factor: 3.396

4.  Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development.

Authors:  Xian Wang; Christopher Sistrunk; Paula L Miliani de Marval; Yongbaek Kim; Marcelo L Rodriguez-Puebla
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

5.  Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma.

Authors:  Hong-Bing Ma; Hai-Tao Hu; Zheng-Li Di; Zuo-Ren Wang; Jing-Sen Shi; Xi-Jing Wang; Yi Li
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

6.  Benzo[a]pyrene-induced cell cycle progression is through ERKs/cyclin D1 pathway and requires the activation of JNKs and p38 mapk in human diploid lung fibroblasts.

Authors:  Hong Ju Du; Ning Tang; Bing Ci Liu; Bao Rong You; Fu Hai Shen; Meng Ye; Ai Gao; Chuan shu Huang
Journal:  Mol Cell Biochem       Date:  2006-05-13       Impact factor: 3.396

7.  Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma.

Authors:  Ratnesh Kumar Singh; Santanu Dasgupta; Nilanjana Bhattacharya; Neelanjana Chunder; Ranjit Mondal; Anup Roy; Syamsundar Mandal; Susanta Roychowdhury; Chinmay Kumar Panda
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-15       Impact factor: 4.553

Review 8.  Aberrant cell cycle regulation in cervical carcinoma.

Authors:  Young Tae Kim; Min Zhao
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

9.  Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.

Authors:  Sang-Hyuk Chung; Kerri Wiedmeyer; Anny Shai; Kenneth S Korach; Paul F Lambert
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

10.  TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.

Authors:  Min Zheng; Ronald Simon; Martina Mirlacher; Robert Maurer; Thomas Gasser; Thomas Forster; Pierre Andre Diener; Michael J Mihatsch; Guido Sauter; Peter Schraml
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.